What are the contraindications for a coronary calcium computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CT Calcium Score Contraindications

CT calcium scoring has very few absolute contraindications, but should not be performed in asymptomatic individuals for screening purposes, and is generally not recommended in men <40 years old or women <50 years old due to very low prevalence of detectable calcium in these age groups 1.

Absolute Contraindications

Pregnancy is the primary absolute contraindication due to radiation exposure concerns, though this is not explicitly stated in the guidelines, it follows standard radiation safety principles.

Strong Relative Contraindications (Class III - Not Recommended)

Screening in Asymptomatic Low-Risk Patients

  • Persons at low risk (<6% 10-year risk) should not undergo CAC measurement 1
  • The test provides minimal clinical utility when baseline risk is already very low

Age-Based Limitations

  • Generally should not be performed in men ≤40 years old and women ≤50 years old due to very low prevalence of detectable calcium 1
  • The radiation exposure cannot be justified given the extremely low yield in these populations

Not for Diagnosis of Obstructive CAD

  • Coronary calcium detection by CT is not recommended to identify individuals with obstructive CAD 2, 3
  • CAC scoring only detects calcified plaque; it cannot visualize the coronary lumen or identify non-calcified plaque
  • The absence of CAC does not exclude obstructive disease, particularly in symptomatic patients 4

Clinical Context Considerations

When CAC Scoring Adds Limited Value

Very High-Risk Patients:

  • Patients already meeting criteria for high-intensity statin therapy based on risk factors alone
  • Those with established ASCVD or diabetes (already warrant aggressive treatment)
  • Patients with LDL-cholesterol ≥190 mg/dL (already require statin therapy)

Patients Unwilling to Act on Results:

  • If the patient will not modify treatment regardless of the CAC score result
  • When lifestyle modifications or pharmacotherapy are already refused

Technical Limitations (Not Contraindications)

While not absolute contraindications, be aware that CAC scoring:

  • Involves radiation exposure (approximately 1-1.5 mSv, equivalent to 1-2 mammograms) 1
  • May identify incidental findings requiring follow-up (lung nodules in 0.4-16.5% of cases) 4
  • Requires cost consideration as not all payors cover the procedure 4

Key Clinical Pitfall

Do not confuse CAC scoring with coronary CT angiography (CTA). The contraindications differ significantly. CTA requires contrast administration and has additional contraindications including:

  • Renal dysfunction
  • Contrast allergy
  • Irregular heart rhythm
  • Inability to cooperate with breath-holding 2, 3

CAC scoring is a non-contrast study and does not share these limitations 1.

Appropriate Use

CAC scoring is reasonable (Class IIa) for:

  • Asymptomatic adults at intermediate risk (10-20% 10-year risk) 1
  • Risk refinement when treatment decisions are uncertain 1

May be considered (Class IIb) for:

  • Persons at low-to-intermediate risk (6-10% 10-year risk) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.